Exploratory analyses showed a higher proportions of patients with DAS@-CRP < @ in the MTX+ETN group at week @ ( @ % vs @ % , adjusted OR @ ( @ to @ ) , p = @ ) and week @ ( @ % vs @ % , adjusted OR @ ( @ to @ ) , p = @ ) .